Capreomycin is an FDA-approved antibiotic used to treat multidrug-resistant tuberculosis (MDR-TB). It targets and inhibits the growth of Mycobacterium tuberculosis, the bacteria responsible for tuberculosis. Capreomycin is particularly effective against TB strains resistant to other first-line drugs. It is often used in combination with other anti-TB medications to enhance treatment outcomes.
CAT# | R2018 |
CAS | 11003-38-6 |
* Please kindly note that our products and services can only be used to support research purposes (Not for clinical use).
Creative Peptides has accumulated a huge library of peptide knowledge including frontier peptide articles, application of peptides, useful tools, and more!
JIP1, a member of the JIPs family, was first discovered to promote JNK activation by combining multiple componen ...
Discovery and Structure Calcitonin, also called thyrocalcitonin, a protein hormone synthesized and secreted in humans and oth ...
MEN 10376 (Asp-Tyr-D-Trp-Val-D-Trp-D-Trp-Lys-NH2) is an analogue of Neurokinin A (NKA), which has a selective af ...
Guangxitoxin 1E is a KV2.1 and KV2.2 specific channel blocker (IC50 values are 1-3 nM). The experimental results ...
An of Dipeptide A Peptide is a constituent fragment in the structure of a protein and is linked by an amide bond ...